#	Pagina
attuale pagina	/open-h2020/projects/225754/index.html
-1	/open-h2020/per-topic/ebsd/list/index.html
-2	/open-h2020/per-topic/mvm/list/index.html
-3	/open-h2020/per-topic/conjugating/list/index.html
-4	/open-h2020/per-topic/consumptions/list/index.html
-5	/open-h2020/per-topic/immunoactive/list/index.html
-6	/open-h2020/per-topic/remixable/list/index.html
-7	/open-h2020/per-topic/i2d/list/index.html
-8	/open-h2020/projects/210406/index.html
-9	/open-h2020/per-topic/granulate/list/index.html
-10	/open-h2020/per-topic/intensely/list/index.html

Opendata, web and dolomites

Obsidian SIGNED

Obsidian Anastomotic SafeGuard – A powerful and efficient tissue sealant method for reducing the anastomotic leak rate in colorectal surgery

Total Cost €

EC-Contrib. €

Partnership

Views

Obsidian project word cloud

Explore the words cloud of the Obsidian project. It provides you a very rough idea of what is the project "Obsidian" about.

total eliminated significantly autologous preparation leaks completing prepation reduces time fast leak clinical 24 fibrin wound asg procedure instrument selant 2018 rate business minutes leveraging commercialization treating stimulation post reg grant transmission surgery needing 300 disease rates conduct 79m grow 14 ends natural profits tissue sealant ibds applicable issue bovine solid thrombin oceania platelet opportunity 42m astonishing patients added gluing faces p1 market obsidian 3rd huge diseases million decrease biocompatibility sme first colorectal anastomosis 19 intestinal asia cancer stump setting full worldwide contains offers solution risk ibd societal anastomotic 2b considering blood bowel gastrointestinal components 97m healing site adding vivostat revenue resection inflammatory sealing approx

Project "Obsidian" data sheet

The following table provides information about the project.

Coordinator	Vivostat A/S Organization address address: BORUPVANG 2 city: ALLEROD postcode: 3450 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Denmark [DK]
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
Code Call	H2020-SMEInst-2018-2020-1
Funding Scheme	SME-1
Starting year	2019
Duration (year-month-day)	from 2019-12-01 to 2020-04-30

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	Vivostat A/S Vivostat A/S Organization address address: BORUPVANG 2 city: ALLEROD postcode: 3450 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DK (ALLEROD)	coordinator	50˙000.00

Map

Project objective

Obsidian ASG® is the first – and only - autologous fibrin tissue sealant applicable for gastrointestinal anastomosis, that will significantly decrease the anastomotic leak rate, following gastrointestinal resection when treating Inflammatory Bowel Diseases (IBDs) or Colorectal Cancer. The current number of anastomotic leak rates is a large societal issue, as studies show rates as high as 19%. Considering that approx. 1.8 million new cases of colorectal cancer will occur worldwide in 2018 (being the 3rd most common cancer type), the number of leaks is astonishing – and this is only for colorectal cancer. Adding the number of IBD patients needing a resection, Obsidian ASG® faces a market potential of 0.79M patients just in Europe, Asia and Oceania every year. Leveraging on this market opportunity, Obsidian ASG® contains all the components needed for on-site prepation and application of an autologous platelet rich fibrin selant – a preparation that can be completed in less than 30 minutes. As the only product in the market, Obsidian ASG® offers 1) a long-term cost-effective procedure for gluing and sealing intestinal stump-ends; 2) A fast and natural stimulation of wound healing that significantly reduces the anastomotic leak rates; and 3) Full biocompatibility, eliminated risk of blood disease transmission and no thrombin or bovine components added to the blood or Obsidian ASG® solution at any time during the process. Yet, to reach market commercialization, we need to conduct a clinical study of Obsidian ASG® with 300 colorectal pre-surgery patients. The SME P1 grant will be crucial for completing the design of the clinical study as well as setting up key partnerships for the proposed clinical study (to be set up in a SME-2b Instrument Project). As such, the SME-Instrument represents a huge opportunity for Vivostat A/S, as we expect to grow a solid business case year 1-5 post-project, with a total revenue of €24.97M and profits of €14.42M.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "OBSIDIAN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "OBSIDIAN" are provided by the European Opendata Portal: CORDIS opendata.